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Abstract
The current study investigated the mechanism and changes in psychopathology symptoms throughout the COVID-19
outbreak and after peak. Two studies were conducted separately in China during outbreak and the after peak stages, with
2540 participants were recruited from February 6 to 16, 2020, and 2543 participants were recruited from April 25 to May 5,
2020. The network models were created to explore the relationship between psychopathology symptoms both within and
across anxiety and depression, with anxiety measured by the Generalized Anxiety Disorder-7 and depression measured by
the Patient Health Questionnaire-9. Symptom network analysis was conducted to evaluate network and bridge centrality, and
the network properties were compared between the outbreak and after peak. Noticeably, psychomotor symptoms such as
impaired motor skills, restlessness, and inability to relax exhibited high centrality during the outbreak, which still relatively
high but showed substantial remission during after peak stage (in terms of strength, betweenness, or bridge centrality).
Meanwhile, symptoms of irritability (strength, betweenness, or bridge centrality) and loss of energy (bridge centrality)
played an important role in the network after the peak of the pandemic. This study provides novel insights into the changes
in central features during the different COVID-19 stages and highlights motor-related symptoms as bridge symptoms, which
could activate the connection between anxiety and depression. The results revealed that restrictions on movement were
associated with worsen in psychomotor symptoms, indicating that future psychological interventions should target motor-
related symptoms as priority.
Introduction
The COVID-19 pandemic has caused substantial threats to
people’s physical health and lives, as well as triggered
psychological distresses such as anxiety and depression [1].
Unlike previous infections, worldwide mass media reports
have highlighted the unique threat of COVID-19, increasing
people’s psychological distress and panic [2]. COVID-19 is
considered highly contagious and currently there is no tar-
geted medical treatment available, instead reducing expo-
sure to the virus is considered to be the best prevention
strategy [2]. However, the negative effects of COVID-19 on
mental health could be exacerbated by prevention-related
measures, such as social distancing and isolation, resulting
in a continued fear and panic toward the virus [3]. There-
fore, timely mental health care has been required during this
pandemic [4]. In order to provide the general public with
appropriate mental health care, researchers have made an
urgent call for guidance and practical evidence to inform the
creation of both health and psychological interventions [5].
A number of recent studies have focused on mental health
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problems during COVID-19, with the most frequently
reported symptoms being depression and anxiety aspects
[1, 6, 7]. A meta-analysis on the mental health within the
general population during the COVID-19 pandemic repor-
ted the prevalence of anxiety to be 31.9% (95% CI:
27.5–36.7) and the prevalence of depression as 33.7% (95%
CI: 27.5–40.6) [8]. When understanding mental health
problems, co-occurrence becomes a complex and principal
issue in regards to treatment adherence and engagement in
prevention measures [9]. Considerations to better under-
stand co-occurrence during the pandemic are required.
Depression and anxiety are commonly co-occur at high
rates, with a co-occurrence of depression and anxiety
resulting in more severe and chronic psychopathology
[10, 11]. Several theoretical models have been proposed to
explain the co-occurrence of anxiety and depression; the
diathesis-stress model proposes a simultaneously develop-
ment of symptoms and left untreated anxiety could increase
the risk of depressive disorders and vice versa [12–15].
However, there is no universal agreement to explain the co-
occurrence of anxiety and depression. In order to further
investigate the relationship between anxiety and depression,
the current study applied network analysis.
To interpret the mechanisms of any underlying psycho-
pathology and develop effective interventions, it is essential
to characterize the interactions between the two different
mental disorders. Network models describe mental dis-
orders using an interacting web of symptoms, which can
offer new insight into co-occurrence [9, 16]. According to
Network Theory, the symptoms of a mental disorder can
lead to development of another disorder; the co-occurrence
belongs to a dynamic network of symptoms that cause,
sustain, and underlie the symptomology [17, 18]. Bridge
symptoms can be regarded as the symptoms that connect
two mental health disorders, and the activation of the bridge
symptoms increase the risk of symptoms transferring from
one disorder to another [9]. Thus, the identification of
bridge symptoms between depression and anxiety could
provide meaningful clinical implications to prevent co-
occurrence. This could be done through applying targeted
and prioritized treatment for bridge symptoms to control
and prevent activation that can lead to the co-occurring
symptoms between depression and anxiety. During the
pandemic, there has been a dramatic decreases in indivi-
duals’ social activities [2]. Considering the preventative
measures of quarantine, social distancing, and lockdown,
people’s mobile-related activities have been largely
reduced. It is likely that motor-related symptoms could then
be considered bridge symptoms between anxiety and
depression.
To understand how symptoms change over time, several
studies have focused on psychologically related distresses
during different COVID-19 stages, with a lack of consensus
within the studies’ results. In a recent longitudinal study on
mental health during COVID-19, no significant changes in
anxiety and depression were found in the general Chinese
population between the initial outbreak and the after peak
period [6]. On the other hand, Qiu et al. [1] conducted a
national survey among Chinese individuals and found that
the distress caused by COVID-19 decreased significantly
over time among the general public. However, the existing
studies did not investigate the mechanism and changes in
anxiety and depressive symptoms throughout the COVID-19
outbreak and the after peak using network analysis. A
recently developed symptom network perspective has high-
lighted the importance of not only measuring whether
symptoms have changed but measuring the interactions
between individual symptoms [19–21]. Using network ana-
lysis may then provide a more in-depth understanding on the
dynamic changes between symptoms of depression and
anxiety at different points throughout the pandemic. The
researchers aimed to assess the interactions between anxiety
and depressive symptom over the outbreak and peak of
COVID-19, and to identify the bridge symptoms (i.e.,
depressive symptoms with strong associations with anxiety
symptoms) using network analysis. Considering the COVID-
19-related prevention measures of social distancing and iso-
lation, we hypothesized that motor-related symptoms would
be the bridge symptoms between depression and anxiety.
Materials and methods
Study sample
The current survey included a total of 5274 Chinese parti-
cipants who completed a surveyed via “Wenjuanxing,” a
Chinese online platform providing functions equivalent to
Qualtrics. The location was verified by participants’ cell-
phone GPS trackers. To avoid duplication of data, each IP
address was only granted access once to complete the
questionnaire.
Detailed data collection information, inclusion and
exclusion criteria, and demographic information are
described in Supplementary information. A total of 5083
participants were included in the analysis. Specifically,
2540 participants (mean age= 25.28 ± 8.07, education
years= 15.93 ± 1.82) were surveyed during the outbreak
stage from February 6 to 16, 2020 (Fig. 1). And, 2543
participants (mean age= 22.03 ± 6.30, education years=
15.97 ± 1.26) were surveyed during the after peak stage.
The study was approved by the ethics committee of Central
University of Finance and Economics and The Second
Xiangya Hospital of Central South University.
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Assessment of psychopathology symptoms
The Patient Health Questionnaire-9 (PHQ-9)
Depression symptoms were assessed via the nine-item
PHQ-9 [22]. The items of PHQ-9 and their reference names
are listed in Table S1. The scales for the questionnaire are in
a four-point Likert format where participants evaluate their
symptoms on a scale from 0 (not at all) to 3 (nearly every
day), with higher scores indicating severe symptoms. The
validated Chinese version uses a cutoff score of 5 to
determine whether a participant had mild depression
symptoms, and the same cutoff score was used for this
study [22–24]. The Cronbach’s alpha was 0.915.
The Generalized Anxiety Disorder Scale (GAD-7)
Anxiety symptoms were assessed using the seven-item
GAD-7 Scale [25]. The items of GAD-7 and their reference
names are listed in Table S1. The scales consist of a four-
point Likert format, in which participants evaluate their
symptoms on a scale from 0 (not at all) to 3 (nearly every
day), with higher scores indicating severe symptoms. The
validated Chinese version uses a cutoff score of 5 to
determine whether a participant has at least mild anxiety
symptoms, and was also used to determine the cutoff score
for this study [23, 26, 27]. The Cronbach’s alpha was
0.941.
Analytical strategies
The changes of sum scores for depression and anxiety were
compared, respectively, between the outbreak and after
peak stages using two-tailed independent t-tests, with the
significance level set as 0.05. The network analysis was
then performed in the aspects of network estimation, net-
work stability, and network differences [28].
Network estimation
In accordance with network parlance, the scores of the items
were considered as nodes and the pair-wise correlations
between these scores were considered as edges [18, 29–32].
To estimate the symptom network illustrating the relationship
between depression and anxiety symptoms, pair-wise Pearson
correlations were run and a sparse Gaussian graphical model
with the graphical lasso was performed to estimate the net-
work [33]. The tuning parameter was decided upon using the
extended Bayesian information criterium [34]. Within this
procedure, symptom networks at outbreak and after peak
stages were estimated. The R package “bootnet” was utilized
to complete this analysis [35]. The network structure was
characterized by network centrality indices, this is where each
node is placed within a weighted network, i.e., strength,
closeness, and betweenness [36, 37]. Specifically, strength is
the sum of edge weights directly connected to a node, which
measures the importance of a symptom in the network.
Closeness is the inverse of the average shortest path length
between a node and other nodes, it measures how close the
symptom is linked to other symptoms. Betweenness is the
number of times that the shortest path between any two nodes
passes through another node and measures the importance of
the symptom in linking to other symptoms. The “centrality
Plot” function from “qgraph” package in R was used to
complete this analysis [38]. The role of a symptom as a
bridge between anxiety and depressive symptoms was also
assessed. Similar to the network centrality, the bridge cen-
trality, which includes bridge strength, bridge closeness, and
bridge betweenness, of each symptom was analyzed. The
only difference between network and bridge centrality is that
the associated two symptoms, as mentioned above, are from
different disorders. The bridge centrality of the nodes mea-
sures the importance of a symptom in linking two mental
health disorders. The complete this analysis the R package
“networktools” [39] was used.
Fig. 1 Symptom network at
outbreak and after peak
stages. The line chat illustrates
the data collection periods and
the daily confirmed new cases in
mainland China. The green
nodes denote the GAD-7 items
and the orange nodes denote the
PHQ-9 items. Meanwhile, the
blue edges denote the positive
correlations and the red edges
denote the negative correlations.
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Network differences
After checking the stability of the network structure (see
Supplementary information), the symptom connections and
the network properties, as mentioned above, were com-
pared. The comparison was between the outbreak and the
after peak stages to allow for any symptom network chan-
ges caused by the pandemic to be quantified. The differ-
ences were quantified using permutation tests with 1000
iterations [40, 41] using the R package “Network Com-
parison Test” [42]. Specifically, participants were randomly
assigned into two group (within the outbreak group and the
same within the after peak group). Then the symptom net-
works were constructed, estimated, and compared using a
bootstrap method of resampling by repeating 1000 times to
get the null distribution of the network differences under the
null hypothesis. The significance level was set as 0.05.
In addition, the network differences in both edge and
network properties, in global and local level, were com-
pared. The global differences in edge weights were mea-
sured by the largest difference in paired edges between two
networks. Meanwhile, the local edge weight differences
were also separately measured. In addition, the global dif-
ference in strength was measured by the difference between
average strength. Finally, the differences in local network
properties were also measured separately.
Results
General differences in symptom scores
The severity of each disorder, between outbreak and after
peak stages, was compared. It was found that participants at
the after peak stage were more depressed than that at the
outbreak stage (PHQ-9, MAfter Peak= 4.72, MOutbreak= 4.17,
t5075.5= 4.0313, p < 0.001). However, the anxiety disorder
scale scores (GAD-7) showed no difference between these
two stages (MAfter Peak= 3.60, MOutbreak= 3.57). Using the
cutoff score of 5 (at least experiencing mild depression and
anxiety symptoms), after the peak stage, 42.94% of the
participants showed depression symptoms, which is sig-
nificantly higher (χ2= 24.29, p < 0.001) than that in out-
break stage (36.14%). Meanwhile, we found more
participants showed anxiety symptoms (χ2= 10.57, p=
0.001) after peak (36.41%), compared to the outbreak stage
(32.05%).
Network estimation and comparison
The estimated networks are displayed in Fig. 1. Detailed
edges weights are listed in Tables S2 and S3. The symptom
network at outbreak stage showed different patterns
regarding the number and thickness of the edges. Before
characterizing the network properties and quantifying the
property differences, the stability of the symptom networks
during outbreak and after peak stages was evaluated by
using the bootstrap method, results are displayed in Figs. S1
and 2. These figures showed that most of the edges and
centrality were stable. Detailed results are provided in
Supplementary information. Therefore, the network differ-
ences between the outbreak and after peak stages reflect
solid changes of the psychological interaction patterns that
were caused by the pandemic.
The network differences in both edge and network
properties were compared. No global differences were
found between networks from outbreak and after peak
stages. Globally, according to the permutation test, the
maximum difference (diff, contrast: after peak− outbreak,
same below) between stages in any of the edge weights
from both networks was not significant (the maximum
difference in Edge was between “afraid” and “inability to
relax” symptoms from current networks, diff=−0.16, p=
0.20). Meanwhile, the global strength difference between
Fig. 2 Stability of network
structures. The x-axle indicates
the included portion of cases,
and the y-axle indicates the
correlations between the original
centrality indices with the
estimated centrality after
dropping part of the cases. Lines
with different colors represent
different network properties.
The shades indicate the range
from the 2.5th quantile to the
97.5th quantile.
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outbreak (global strength= 8.38) and after peak (global
strength= 8.24) stages was also found as not significant
(p= 0.70). However, local differences were found in mul-
tiple edges and nodes. Locally, the networks at outbreak and
after peak stages differed not only in symptom connections
(edge weights), but also in network properties (network and
bridge centrality).
Specifically, for the edge weights, the significant positive
and negative correlations were visualized separately in
Fig. 3 (p < 0.05). At the after peak stage, insomnia symptom
from the PHQ-9 showed stronger connections with
impaired motor skills and changes in appetite symptoms
from the GAD-7 as well as with nervous symptoms from
the PHQ-9. No decreased connections with other symptoms
were shown. By contrast, the symptom of inability to relax
from the GAD-7 showed a decreased connection with
symptoms of being afraid, restless, and irritable from the
GAD-7 and also with suicidal thoughts and guilty symp-
toms from the PHQ-9. There were no increased connections
with other symptoms shown. It should also be noted that
during the after peak stage, compared to the outbreak stage,
suicidal thoughts showed a decreased connection with
“inability to relax” and “guilty” symptoms, whereas suicidal
thoughts showed an increased connection with the “too
much worry” symptom. The decreased connection between
feeling guilty and suicidal thoughts from the outbreak stage
to the after peak stage is also illustrated in Fig. S1, in which
the edge weights, no matter if from the current sample or
bootstrapped sample, ranked at the top in the outbreak stage
and dropped to number nine in the after peak stage.
For the network properties, bar plots indicate the network
and bridge centrality of each symptom in each stage as
displayed in Fig. 4. During the outbreak, psychomotor
symptoms such as impaired “motor skills, restless, and
inability to relax” exhibited high network betweenness and
bridge betweenness. While during the after peak stage,
although these symptoms decreased, they were still rela-
tively high when compared with other symptoms. These
symptoms might not necessarily exhibit intensive connec-
tions with other symptoms. However, they stand between
the associated symptoms, which may have played a key role
as a mediator that regulated the connections between the
symptoms in the network [43]. Moreover, besides these
symptoms, several other symptoms also showed increased
network and bridge centrality during the after peak stage.
In specific, using permutation tests, it was found that the
“inability to relax” symptom showed a decreased strength at
the after peak stage (diff=−0.16, p= 0.03) when com-
pared to the outbreak stage. Meanwhile, the “restlessness”
symptom exhibited decreased betweenness (diff=−25,
p= 0.04) and the “impaired motor sills symptom” showed
decreased betweenness (diff=−26, p= 0.01), bridge clo-
seness (diff=−0.021, p= 0.048), and bridge betweenness
(diff=−27, p= 0.01). By contrast, the “irritable” symptom
showed increased strength (diff= 0.22, p= 0.02),
betweenness (diff= 14, p= 0.03), and bridge betweenness
(diff= 14, p= 0.02) during the after peak stage, compared
to the outbreak stage. Meanwhile, the “loss of energy”
symptom showed increased bridge closeness (diff= 0.016,
p= 0.03) and bridge betweenness (diff= 11, p= 0.02).
Discussion
The novelty of the current study was to evaluate the psy-
chopathological symptom changes between the outbreak
Fig. 3 Edges exhibiting
significant differences between
outbreak and after peak
stages. The green nodes denote
the GAD-7 items and the orange
nodes denote the PHQ-9 items.
Meanwhile, the blue edges
denote the increased correlations
between items at the after peak
stage when compared with those
in the outbreak stage and the red
edges denote the decreased ones.
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and after peak in China, which have significant implications
for other countries that still have not reached their after
peak. The current study identified the bridge symptoms and
aimed to identify the risks of co-occurrence between anxiety
and depressive symptoms during different phrases of
COVID-19 to prevent increasing psychological distress.
The network differences and changes between outbreak and
after peak stages showed the impact of the COVID-19
pandemic on psychological interaction patterns.
The prevalence of anxiety and depression in this study
during outbreak was 32.05% and 36.14%, and during after
peak phase was 36.41% and 42.94%. Similar to the meta-
analysis on depression and anxiety during the COVID-19,
over one-third of the population suffered from anxiety and
depressive symptoms [8]. Researchers have suggested that
the mental health consequences of COVID-19 could last
over time and that mental health problems could peak later
than the actual pandemic [3]. Our results were consistent
with the prediction and showed that after the COVID-19
peak the prevalence of depression and anxiety increased.
This could due to the far-reaching influences of COVID-19,
such as the induced economic uncertainty, the fear of eco-
nomic crisis and recession, and increased unemployment
[44, 45]. These aftereffects could all work toward increasing
anxiety and depression after the actual pandemic peak.
Research has noted that different mental health problems
have emerged during the COVID-19 outbreak, which
mainly included anxiety and depression [46]. Previous
research has examined the symptoms of anxiety and
depression using network analysis in psychiatric patients
and found that sad mood and worry were the most central
symptoms in the network [28]. In the current study, during
the outbreak stage psychomotor symptoms such as impaired
motor skills, restlessness, and inability to relax were the
most central symptoms in the network. During the after
peak stage these symptoms showed a decreased centrality
but were still relatively high when compared with other
symptoms. In addition, the irritable symptom showed
increased centrality during the after peak stage. That is, after
the peak time, psychomotor centrality decreased, while the
mental health problems were more severe due to the con-
tributions from other non-psychomotor-related aspects.
After the pandemic peak time, normal social activities
started to resume. This could explain why people’s physi-
cal- and motor-related activities began to show normality as
the psychomotor-related symptoms would be eased.
However, the mental health problems caused by the
pandemic could have prolonged effects [3] and people
might be anxious and depressed from other non-
psychomotor aspects. During the COVID-19 period, there
was a perceived decrease in physical-related activities [2],
which correspond with the central symptoms identified from
the data. Compared with the non-symptomatic group,
depressed patients presented disturbances in psychomotor
Fig. 4 Network and bridge centrality. GAD-7: Generalized Anxiety Disorder-7; PHQ-9: Patient Health Questionnaire-9.
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symptoms in terms of motor activities, body movement, and
motor reaction time [47–49]. Researchers have proposed
that psychomotor symptoms may have unique significance
in depression, which could explain the psychomotor mani-
festations and pathophysiologic significance of depression
[47]. Restless-agitation in anxiety is also related to psy-
chomotor functions, in which the higher level of restless-
agitation indicated more severe anxiety [25].
After assessing the interactions between anxiety and
depressive symptoms, it was identified that the bridge
symptoms during the outbreak also focused on psychomotor
symptoms such as impaired motor skills, restlessness, and
inability to relax. In particular, the impaired motor skill
symptoms showed a significant decrease in bridge centrality
during the after peak phase, although it was still relatively
high when compared with other symptoms. Meanwhile, it
was also observed that the inability to relax showed
decreased connections with being afraid, restlessness, sui-
cidal thoughts, and feelings of guilt. In addition, during the
after peak phase, other bridge symptoms such as irritable
and loss of energy emerged, which showed higher bridge
centrality than the outbreak stage. In a risky network, the
connections among symptoms are tight and strong, and the
activation of one symptoms could lead to others, resulting
in more severe consequences [28, 30]. During the outbreak
and after peak, the occurrence of either impaired motor
skills with depression symptoms or restlessness with anxi-
ety symptoms could increase the risk of activation for other
mental disorders. This was different from a previous study
conducted during the pre-pandemic period. Previous net-
work analysis has shown that the association of anxiety and
depression can be attributed to the strong connection from
anxious worrying to sleep problems and difficulty con-
centrating [50]. Our results also indicated that during the
after peak insomnia showed enhanced connections with
appetite changes, impaired motor skills, and nervous
symptoms.
Compared to the non-pandemic period, there have been a
wide-scale lockdown and restrictions on transportation
during the COVID-19 pandemic. The beneficial effects of
physical health on mental health have been well-
documented in research [51, 52]. COVID-19 is having a
negative impact on people’s physical activity on a global
level [53, 54]. Recent COVID-19 research in psychiatric
patients also reported that poor physical health was related
with higher levels of anxiety and depression [55]. This
could explain why the impaired motor skills aspect and
restlessness become the bridge symptoms between anxiety
and depression.
Depression and anxiety are frequently co-occurring
mental disorders, and previous research has indicated the
likelihood of a causal relationship between these two mood
disorders [50]. A cognitive neuroscience study using default
model network (DMN) indicated that cortical areas of the
DMN showed functional connectivity associated with
anxiety and depression [56]. Similar to previous studies, the
current study cannot confirm the causal relation between
anxiety and depression. However, the current network
analysis can be utilized in clinical practice during the
COVID-19 period. A previous study suggested that inter-
ventions should focus on depression and anxiety symptoms
which are most closely related to other symptoms, since
those symptoms should theoretically decrease the associated
risk [57]. Moreover, symptoms with a high centrality may
also have crucial roles in the network [58]. Those core
symptoms could have important roles in maintaining the
psychopathology network and treating those symptoms
could help to cure the psychopathology. That is, for treating
COVID-19-related mood problems, the study results sug-
gest clinical practitioners to focus on the symptoms high-
lighted by our network analysis.
Researchers have expressed concern about the con-
sequence of mental disorders resulting from the COVID-19
pandemic [59] and mental health professionals have
speculated a globe increase of mental disorders due to the
impact of COVID-19 [60, 61]. WHO has also mentioned
that COVID-19 related specific measures, such as self-iso-
lation, quarantine, and social distancing, might increase
loneliness and mood-related problems such as anxiety and
depression in people [62]. Our results showed that during
the after peak phase, the impaired motor-skill-related
symptoms were still prominent. It is hard to predict the
duration of the COVID-19 crisis, especially as cities such as
Leicester, United Kingdom [63] are undergoing a second
lockdown. It is possible that impaired motor-skill-related
symptoms could persistent in people in the second lock-
down control zones. During the COVID-19 lockdown,
physical health professionals have recommended people to
stay active with home-based physical activities in order to
maintain their health, engaging in activities such as aerobic
exercise training and body weight training [53]. A healthy
lifestyle and regular exercise are associated with an
enhanced immune system [2], which could help protect
people from COVID-19-related health problems. This study
suggests that health professionals could provide tailored and
practical suggestions for the general population by targeting
mood symptoms through exercise as a prevention or as a
treatment strategy. Researchers have proposed to use
mindfulness-based stress reduction practices to improve
mental health during the COVID-19 [64–66]. In the current
literature, mindfulness-based interventions have shown
effectiveness in reducing anxiety and depression [67, 68].
There are several limitations to the study that should be
acknowledged. First, depression and anxiety were measured
by self-reported questionnaires rather than systematic
diagnosis. Second, this network analysis on depression and
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anxiety focused specifically on the COVID-19 pandemic
and cannot be generalized to non-pandemic times. There-
fore, the central symptoms and bridge symptoms identified
in the current study may not applicable during other peri-
ods. Third, the age of the participants was relatively young.
Fourth, due to the cross-sectional design, causal relationship
could not be established. Future longitudinal studies are
needed to investigate the causal relationship between
anxiety and depression. Finally, the study did not measure
the changes in physical health and the degree of reduction in
physical activities during COVID-19.
In conclusion, this is the first network analysis focusing
on psychopathological symptoms during the COVID-19
pandemic, which provides valuable insights to understand
the interactions between depression and anxiety. The cur-
rent findings indicated the central symptoms and bridge
symptoms during the COVID-19 outbreak and after peak
stages in order to provide clinical suggestions for psycho-
logical interventions that target reducing the co-occurrence
of symptoms between different mental health problems.
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